Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ.

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public.